Assistance Publique Hopitaux de Marseille

Marseille 13385

0 studies enrolling now · 4 studies all time

What they study most

Familial Chylomicronemia Syndrome, Locally Advanced Head and Neck Squamous Cell Carcinoma, Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL), Ph+ Mixed Phenotype Acute Leukemia (MPAL), Philadelphia Chromosome-Like ALL (Ph-like ALL), Recurrent Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck, Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Studies at this site

• A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) — Running, not enrolling
• A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia — Stopped early
• Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN — Withdrawn before enrolling
• A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) Administered to Patients With Familial Chylomicronemia Syndrome (FCS) — Completed